Honglei Zhang

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Japanese encephalitis virus NS1 and NS4B synergistically target TLR3 signaling to promote viral replication.

Japanese encephalitis virus NS1 and NS4B synergistically target TLR3 signaling to promote viral replication.

Journal: mBio

Published: May 01, 2026

Development of colloidal gold and carbon immunochromatographic strips for rapid detection of PDCoV.

Development of colloidal gold and carbon immunochromatographic strips for rapid detection of PDCoV.

Journal: iScience

Published: February 10, 2026

Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Journal: Nature communications

Published: December 15, 2025

TGEV activates RIG-I/IFN-β/STAT1 axis to promote NLRC5-mediated SLA-I upregulation.

TGEV activates RIG-I/IFN-β/STAT1 axis to promote NLRC5-mediated SLA-I upregulation.

Journal: Veterinary research

Published: November 26, 2025

Identification and characterization of two novel linear B cell epitopes on the envelope protein of Japanese encephalitis virus.

Identification and characterization of two novel linear B cell epitopes on the envelope protein of Japanese encephalitis virus.

Journal: International journal of biological macromolecules

Published: October 09, 2025

Design of Mucosal Vaccines Against Swine Enteric Coronaviruses: From Antigen Delivery to Immune Activation.

Design of Mucosal Vaccines Against Swine Enteric Coronaviruses: From Antigen Delivery to Immune Activation.

Journal: Transboundary and emerging diseases

Published: September 20, 2025

Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1.

Pathogenicity, virological features, and immune evasion of SARS-CoV-2 JN.1-derived variants including JN.1.7, KP.2, KP.3, and KP.3.1.1.

Journal: Nature communications

Published: April 10, 2025

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Journal: Research square

Published: November 28, 2024

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Journal: Nature communications

Published: November 14, 2024

TGEV nonstructural protein ORF3b upregulates the expression of SLA-DR at the transcriptional level in monocyte-derived porcine dendritic cells.

TGEV nonstructural protein ORF3b upregulates the expression of SLA-DR at the transcriptional level in monocyte-derived porcine dendritic cells.

Journal: Microbes and infection

Published: August 12, 2024

Porcine deltacoronavirus nucleocapsid protein antagonizes JAK-STAT signaling pathway by targeting STAT1 through KPNA2 degradation.

Porcine deltacoronavirus nucleocapsid protein antagonizes JAK-STAT signaling pathway by targeting STAT1 through KPNA2 degradation.

Journal: Journal of virology

Published: June 03, 2024

Rapid Construction of Recombinant PDCoV Expressing an Enhanced Green Fluorescent Protein for the Antiviral Screening Assay Based on Transformation-Associated Recombination Cloning in Yeast.

Rapid Construction of Recombinant PDCoV Expressing an Enhanced Green Fluorescent Protein for the Antiviral Screening Assay Based on Transformation-Associated Recombination Cloning in Yeast.

Journal: Journal of agricultural and food chemistry

Published: January 05, 2024

Showing 1-12 of 25

Last Updated: 09/26/2026